Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy
Achille Bottiglieri, Pierangela Sepe, Marco Stellato, Chiara Pircher, Giuseppe Fotia, Alberto Giovanni Leone, Valentina Guadalupi, Melanie Claps, Patrizia Giannatempo, Elena Verzoni, Giuseppe Procopio Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyCorrespondence...
Main Authors: | Bottiglieri A, Sepe P, Stellato M, Pircher C, Fotia G, Leone AG, Guadalupi V, Claps M, Giannatempo P, Verzoni E, Procopio G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/optimal-choice-of-adjuvant-treatment-for-renal-cell-carcinoma-followin-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
by: Pierangela Sepe, et al.
Published: (2021-07-01) -
Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
by: Beata Franczyk, et al.
Published: (2023-01-01) -
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
by: Ilaria Grazia Zizzari, et al.
Published: (2020-09-01) -
Adjuvant therapy for renal cell carcinoma, finally a new standard?
by: Alex Renner, et al.
Published: (2022-09-01) -
Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma
by: Nikolas Dovrolis, et al.
Published: (2023-11-01)